Literature DB >> 31346761

Bipolar endoscopic enucleation versus bipolar transurethral resection of the prostate: an ESUT systematic review and cumulative analysis.

Davide Arcaniolo1, Celeste Manfredi1, Alessandro Veccia2,3, Thomas R W Herrmann4, Estevão Lima5, Vincenzo Mirone6, Ferdinando Fusco6, Cristian Fiori7, Alessandro Antonelli3, Jens Rassweiler8, Evangelos Liatsikos9, Francesco Porpiglia7, Marco De Sio1, Riccardo Autorino10,11.   

Abstract

PURPOSE: To perform a cumulative analysis of the current evidence on the surgical and functional outcomes of bipolar endoscopic enucleation of the prostate (b-EEP) versus bipolar transurethral resection of the prostate (b-TURP).
METHODS: A systematic review of the literature was performed on PubMed, Ovid®, and Scopus® according to Preferred Reporting Items for Systematic Review and Meta-analysis Statement (PRISMA Statement). The meta-analysis was conducted using the Review Manager 5.3 software. Parameters of interest were surgical and functional outcomes. Weighted mean difference, and odds ratio with 95% confidence interval were calculated for continuous and binary variables, respectively. Pooled estimates were calculated using the random-effect model.
RESULTS: Fourteen comparative studies were included. No statistically significant difference in terms of overall baseline characteristics was found. b-EEP had higher amount of resected tissue (p < 0.0001), shorter catheter time (p = 0.006), lower Hb drop (p = 0.03), and shorter length of stay (p < 0.0001). Equally, overall post-operative complications were lower (p = 0.01) as well as short (p = 0.04), and long-term complication rate (p = 0.04). There was higher re-intervention rate in the b-TURP group (p = 0.02) whereas b-EEP group had smaller residual prostate volume (p = 0.03), and lower post-operative PSA values (p < 0.00001). At long term, b-EEP presented lower IPSS (p = 0.04), higher Qmax (p = 0.002), and lower PVR (p < 0.00001).
CONCLUSIONS: b-EEP is an effective and safe surgical treatment for BPO. This procedure might offer several advantages over standard b-TURP, including the resection of a larger amount of tissue within the same operative time, shorter hospitalization, lower risk of complications, and lower re-intervention rate. This was submitted to PROSPERO registry: CRD42019126748.

Entities:  

Keywords:  BPO; Benign prostate obstruction; Bipolar transurethral resection of the prostate; Bladder outlet obstruction; EEP; Endoscopic enucleation of prostate; Systematic review; TURP; Transurethral enucleation

Mesh:

Year:  2019        PMID: 31346761     DOI: 10.1007/s00345-019-02890-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  7 in total

Review 1.  Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review.

Authors:  Sachin Malde; Wayne Lam; Zainal Adwin; Hashim Hashim
Journal:  BJUI Compass       Date:  2021-02-03

2.  Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.

Authors:  Sascha A Ahyai; Irina Marik; Tim A Ludwig; Andreas Becker; Saman Asdjodi; Luis Kluth; Felix Chun; Margit Fisch; Marianne Schmid
Journal:  World J Urol       Date:  2020-02-21       Impact factor: 4.226

3.  Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?

Authors:  Jaegeun Lee; Seung Woo Yang; Long Jin; Chung Lyul Lee; Ji Yong Lee; Ju Hyun Shin; Jae Sung Lim; Ki Hak Song
Journal:  BMC Cancer       Date:  2021-04-28       Impact factor: 4.638

4.  Comparison of Outcome and Quality of Life Between Thulium Laser (VelaTM XL) Enucleation of Prostate and Bipolar Transurethral Enucleation of the Prostate (B-TUEP).

Authors:  Yu-Ting Chen; Chen-Pang Hou; Horng-Heng Juang; Yu-Hsiang Lin; Pei-Shan Yang; Phei-Lang Chang; Chien-Lun Chen; Shu-Chuan Weng; Ke-Hung Tsui
Journal:  Ther Clin Risk Manag       Date:  2022-02-24       Impact factor: 2.423

5.  Lasers in Transurethral Enucleation of the Prostate-Do We Really Need Them.

Authors:  Thomas R W Herrmann; Stavros Gravas; Jean Jmch de la Rosette; Mathias Wolters; Aristotelis G Anastasiadis; Ioannis Giannakis
Journal:  J Clin Med       Date:  2020-05-10       Impact factor: 4.241

Review 6.  [Surgical treatment of benign prostatic obstruction (BPO) in patients under anticoagulation: a review of the bleeding risks of established techniques].

Authors:  S Deininger; T Herrmann; S Schönburg; P Törzsök; T Kunit; L Lusuardi
Journal:  Urologe A       Date:  2020-10       Impact factor: 0.639

7.  TURPxit or not: contemporary management options for benign prostatic obstruction.

Authors:  Thomas R W Herrmann; Vincent Misrai; Fernando Gómez Sancha; Thorsten Bach
Journal:  World J Urol       Date:  2021-07       Impact factor: 4.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.